Phys.org reports that a protein involved in regulating how mRNA is decoded can itself be regulated, a finding with implications for understanding cancer. The work centers on METTL13, a translation factor whose methylation allows it to speed the decoding of rare codons, according to Bioengineer.org.
Coverage of the research links this mechanism to tumor growth. News-Medical describes METTL13 as helping cancer cells produce the proteins needed for tumors to grow, while UT MD Anderson frames the work as a newly discovered pathway that fuels production of cancer-driving proteins. EurekAlert! reports that the study identifies translation regulation mechanisms tied to both cancer development and resistance to treatment.
The findings add to a growing body of work on translation control — the steps by which cells turn mRNA instructions into proteins. In this case, the regulation of the decoding machinery itself appears to matter: methylation of the factor changes how efficiently rare codons are read, which in turn supports the protein output cancer cells rely on.
The research is attributed across several outlets, and the underlying study details were not available in the source material. What to watch next: whether this pathway becomes a target for new cancer therapies or a marker for treatment resistance.